VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Daylight Biotherapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Best-in-class immune engagers for solid tumors

  • Biotech & therapeutics
Status
Operatingas of 2026-09-19
Business model
B2B
Founded
2025
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

At Daylight Biotherapeutics we are decoupling tumor killing from systemic immune activation using our novel T cell engaging technology. Our mission is to harness the natural power of the immune system to create safer more effective treatments for patients with cancer.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy